PharmaCadence Analytical Services Revenue and Competitors

Hatfield, PA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • PharmaCadence Analytical Services's estimated annual revenue is currently $3.3M per year.(i)
  • PharmaCadence Analytical Services's estimated revenue per employee is $155,000

Employee Data

  • PharmaCadence Analytical Services has 21 Employees.(i)
  • PharmaCadence Analytical Services grew their employee count by -5% last year.

PharmaCadence Analytical Services's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.6M100%N/AN/A
#2
$4M2613%N/AN/A
#3
$0.9M6-14%N/AN/A
#4
$1.1M70%N/AN/A
#5
$10.9M703%N/AN/A
#6
$0.7M929%N/AN/A
#7
$4M26-16%N/AN/A
#8
$1.7M1122%N/AN/A
#9
$7.6M492%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is PharmaCadence Analytical Services?

PharmaCadence is an analytical services organization serving the pharmaceutical and life sciences fields with expert LC-MS services. We specialize in high quality quantitative LC-MS bioanalytical methods for research and early drug development. Our service offerings include protein and peptide quantitative LC-MS analysis, as well as a full range of ADME in vitro assays along with the complete suite of preclinical PK capabilities. The company founders, Carmen Fernandez-Metzler, Ph.D. and Richard King, Ph.D., are former Merck DMPK scientists with many years of experience discovering and developing new drugs. We pride ourselves in our strong scientific background and our total commitment to excellence. We pay attention to our customer's needs. We believe business is best generated by solving a customer's important problems. Our customers are contributing to a healthier and better world. We want to help.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3M2111%N/A
#2
$4.9M24-17%N/A
#3
$2.2M24-14%N/A
#4
$3.8M264%N/A
#5
$2.6M264%N/A